Agency Regains Its Authority to Regulate Laboratory Developed Tests (LDTs) by Glenn S. Demby | Nov 29, 2021 | Articles, Clinical Diagnostics Insider, Coronavirus, COVID-19, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
AACC Doubles Down on Not Using CT Values to Evaluate Performance of SARS-CoV-2 PCR Tests by Glenn S. Demby | Nov 29, 2021 | Articles, Clinical Diagnostics Insider, Coronavirus, COVID-19, Diagnostic Testing and Emerging Technologies... This content is for Paid Members only.RegisterAlready a member? Log in here
FDA Imposes New Limits on COVID-19 Tests with Access to EUA Pathway by Glenn S. Demby | Nov 29, 2021 | Articles, Clinical Diagnostics Insider, COVID-19, Diagnostic Testing and Emerging Technologies, FDA-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
Agency Regains Its Authority to Regulate Laboratory Developed Tests (LDTs) by Glenn S. Demby | Nov 24, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies... This content is for Paid Members only.RegisterAlready a member? Log in here
FDA Imposes New Limits on COVID-19 Tests with Access to EUA Pathway by Glenn S. Demby | Nov 24, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here